CASEY WILSON: Open Payments
NPI 1043324148 · DELAND, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$844 in 47 payments from 12 companies in 2025. Trend: 2023 $433 · 2024 $1,029 · 2025 $844
Food & beverage: $844
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 14 | $232 |
| ABBVIE INC. | 9 | $168 |
| Abbott Laboratories | 3 | $72 |
| Amgen Inc. | 4 | $69 |
| Lilly USA, LLC | 4 | $67 |
| GlaxoSmithKline, LLC. | 4 | $63 |
| Astellas Pharma US Inc | 3 | $54 |
| AstraZeneca Pharmaceuticals LP | 2 | $42 |
| PhotoniCare Inc | 1 | $22 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
Products named: UBRELVY, Ozempic, FREESTYLE LIBRE 3, Rybelsus, TRELEGY ELLIPTA, Veozah, OTEZLA, Wegovy.
Industry payments across FL — which companies pay providers there.
